Analyst Ratings for GlaxoSmithKline (GSK) [Neutrals]
GSK Rating Summary
GSK Price Target Summary
- Highest: $48.00 (Jefferies)
- Lowest: $44.00 (Morgan Stanley)
- Average: $46.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$46.00 (+12.6%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
Avg. $ Target:
$46.00 (+12.6%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/23/2024 | Morgan Stanley | Mark Purcell | New Coverage | Equalweight (N/A) |
44.00 (N/A) |
39.68 (40.86) |
2.97% | Details |
| 2/11/2022 | DZ Bank | Elmar Kraus | Downgrade | Hold (Buy) |
N/A (N/A) |
44.44 (40.86) |
-8.06% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
